C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
12/2011
12/08/2011	WO2011150682A1 4-hydroxyquinoline-3-amide derivatives and preparation methods and uses thereof
12/08/2011	US20110301348 Process for the Manufacture of the Calcium Salt of Rosuvastatin (E)-7-[4-(4-Fluorophenyl)-6-Isopropyl-2-[Methyl(Methylsulfonyl)Amino]-Pyrimidin-5-yl](3R,5S)-3,5-Dihydroxyhept-6-Enoic Acid and Crystalline Intermediates Thereof
12/08/2011	US20110301347 Benzyl, amines, a process for their production and their use as anti-inflammatory agents
12/08/2011	US20110301208 Viral and fungal inhibitors
12/08/2011	US20110301191 Methods of treatment using selective 5-ht2a inverse agonists
12/08/2011	US20110301151 Dimeric iap inhibitors
12/08/2011	US20110301145 Pyridazinones, method of making, and method of use thereof
12/08/2011	US20110301123 Fungicidal Heterocyclic Amines
12/08/2011	US20110301109 Phenylpyrimidone Compounds, the Pharmaceutical Compositions, Preparation Methods and Uses Thereof
12/08/2011	US20110300074 3,6-disubstituted xanthylium salts
12/08/2011	US20110297924 Aromatic amine derivative and organic electroluminescent element
12/08/2011	CA2801405A1 Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
12/08/2011	CA2801274A1 Compounds for the treatment of clostridium difficile associated disease
12/08/2011	CA2801074A1 Glycine transporter-1 inhibitors, methods of making them, and uses thereof
12/07/2011	EP2392580A1 2'-fluoronucleosides
12/07/2011	EP2392573A1 Quinoline derivative
12/07/2011	EP2392571A2 Indol-3-yl-carbonyl-piperidin and piperazin derivatives
12/07/2011	EP2391617A1 Azetidines as histamine h3 receptor antagonists
12/07/2011	EP2391614A1 Enaminocarbonyl compounds and their use
12/07/2011	EP2391608A1 Fungicide n-cycloalkyl-n-bicyclicmethylene-carboxamide derivatives
12/07/2011	EP2391604A1 Dihydropyridone amides as p2x7 modulators
12/07/2011	EP2391603A1 Aroylamino - and heteroaroylamino-substituted piperidines as glyt-1 inhibitors
12/07/2011	EP2391602A1 Carbazole carboxamide compounds useful as kinase inhibitors
12/07/2011	EP1981881B1 Tetrahydropyrane antibiotics
12/07/2011	EP1965790B1 Metabolites of wortmannin analogs and methods of using the same
12/07/2011	CN1926117B 用于改进感知、注意力、学习效率、和/或记忆力的6-氨基-5-氰基-嘧啶-4-酮类化合物 For improving perception, attention, learning efficiency, and / or memory of the 6-amino-5-cyano - pyrimidin-4-ones
12/07/2011	CN1826324B 吲唑、苯并异唑和苯并异噻唑激酶抑制剂 Indazole, benzoisoxazole oxazole and benzisothiazole kinase inhibitors
12/07/2011	CN102272128A Atp-结合盒转运蛋白的调节剂 Atp- binding cassette transporter protein modifier
12/07/2011	CN102272127A Atp-结合盒转运蛋白调节剂 Atp- binding cassette transporter protein modifiers
12/07/2011	CN102272120A 生物活性酰胺 Bioactive amides
12/07/2011	CN102272107A 嘧啶衍生物及其用于抵抗不希望的植物生长的用途 Pyrimidine derivatives and for combating undesired plant growth purposes
12/07/2011	CN102271678A 2-酰胺基丙醇型葡糖神经酰胺合成酶抑制剂 2-acylaminopropanol type glucosyl ceramide synthase inhibitors
12/07/2011	CN102267990A 一种2,3-二氢苯并呋喃类衍生物及其制备与应用 One kind of 2,3-dihydrobenzofuran derivatives, preparation and application
12/07/2011	CN102267986A 一种吡唑双酰胺类化合物及其合成方法与应用 Pyrazole double-lactam compound and its synthesis method and application
12/07/2011	CN102267985A 维拉佐酮或其盐酸盐的制备方法 Preparation 维拉佐 one or the hydrochloride salt of
12/07/2011	CN102267984A 4-羟基喹啉-3-酰胺衍生物及其制备方法和用途 4-hydroxy-quinoline-3-acid derivatives and their preparation and use
12/07/2011	CN102267978A 作为激酶活性调节剂的1,3-二芳基取代的脲 As the kinase activity of 1,3-diaryl-substituted urea modifier
12/07/2011	CN102267971A 脂环并[c]苯并吡喃酮衍生物及其应用 Alicyclic and [c] benzopyran derivatives and their Applications
12/07/2011	CN102267948A 芴并二咪唑衍生物及其制备方法 Fluorene and two imidazole derivatives and its preparation method
12/07/2011	CN102267932A 4-(5-氰基-1h-吲哚-3-基)丁基取代磺酸酯类化合物及其应用 4- (5-cyano -1h- indol-3-yl) butyl substituted sulfonic acid ester compounds and uses thereof
12/07/2011	CN101519375B 抗真菌的取代吡唑啉化合物及其制备方法和应用 Antifungal substituted pyrazoline compound and preparation method and application
12/07/2011	CN101486673B 一种光学活性2-(2-硝基-乙基)-吡咯的合成方法 An optically active 2- (2-nitro-ethyl) - - synthesis of pyrrole
12/07/2011	CN101367796B 一种三环氧丙基异氰尿酸酯的生产方法 A three-epoxypropyl isocyanurate production methods
12/07/2011	CN101300235B 作为p2x3和p2x2/3调节剂的二氨基嘧啶类化合物 As p2x3 and diamino pyrimidine derivatives p2x2 / 3 modifier
12/06/2011	US8071635 Minimal cardivascular and/or sedatory activity; treating pain and allodynia; selective to alpha2B and/or alpha2C adrenergic receptors in preference over alpha2A adrenergic receptors;
12/06/2011	US8071628 Indazole derivatives
12/06/2011	US8071627 2-pyridinylethylcarboxamide derivatives and their use as fungicides
12/06/2011	US8071618 Caspase inhibitors and uses thereof
12/06/2011	US8071617 Modulators of cellular adhesion
12/06/2011	US8071612 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
12/06/2011	US8071601 Aminoquinoline derivatives and their use as adenosine A3 ligands
12/06/2011	US8071595 1,2-disubstituted heterocyclic compounds
12/06/2011	US8071586 Heterocyclyl compounds
12/06/2011	CA2600570C Benzazole derivatives, compositions, and methods of use as .beta.-secretase inhibitors
12/06/2011	CA2584666C Pyrimidine derivative condensed with a non-aromatic ring
12/06/2011	CA2582029C Aryl nitrogen-containing bicyclic compounds and methods of use
12/06/2011	CA2517573C Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
12/06/2011	CA2504160C Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds
12/06/2011	CA2485430C Process for the preparation of a hydrate of an anthranilic acid derivative
12/06/2011	CA2448482C Human papillomavirus e2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket
12/01/2011	WO2011150022A2 Polymer-conjugated metap2 inhibitors, and therapeutic methods of use thereof
12/01/2011	WO2011149011A1 Novel indazole derivative or salt thereof, manufacturing intermediate therefor, antioxidant using same, and use for an indazole derivative or salt thereof
12/01/2011	WO2011149010A1 Novel indazole derivative or salt thereof, intermediate for the production of same, prophylactic or therapeutic agent for chorioretinal denaturative diseases and therapeutic method for chorioretinal denaturative diseases each utilizing same, and use of indazole derivative or salt thereof
12/01/2011	WO2011148956A1 Fused imidazole derivative
12/01/2011	WO2011148909A1 Organic electroluminescent element
12/01/2011	WO2011147780A1 Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies
12/01/2011	WO2011147772A1 Ccr2 receptor antagonists
12/01/2011	WO2011093524A9 Di - substituted pyridine derivatives as anticancers
12/01/2011	US20110294863 Fungicide n-cycloalkyl-n-bicyclimethylene-carboxamide derivatives
12/01/2011	US20110294851 Amidine-containing compounds useful as muscarinic receptor antagonists
12/01/2011	US20110294850 Indoline derivatives
12/01/2011	US20110294827 Iap binding compounds
12/01/2011	US20110294825 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/01/2011	US20110294824 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/01/2011	US20110294819 Hepatitis C Virus Inhibitors
12/01/2011	US20110294818 1h-quinazoline-2,4-diones
12/01/2011	US20110294812 P38 map kinase inhibitors
12/01/2011	US20110294804 Novel bicyclic heterocyclic compound
12/01/2011	US20110294783 Insecticidal Compositions Having Improved Effect
12/01/2011	US20110294749 Diaminopyrimidinecarboxamide derivative
12/01/2011	US20110293520 New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases
12/01/2011	CA2828605A1 Polymer-conjugated metap2 inhibitors, and therapeutic methods of use thereof
12/01/2011	CA2800724A1 Novel indazole derivative or salt thereof and production intermediate thereof, and antioxidant using same, and use of indazole derivative or salt thereof
12/01/2011	CA2800530A1 Inhibitors of hcv ns5a
12/01/2011	CA2800521A1 Fused imidazole derivative
12/01/2011	CA2800509A1 Inhibitors of hcv ns5a
12/01/2011	CA2800384A1 Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies
11/2011
11/30/2011	EP2390257A1 2'-fluoronucleosides
11/30/2011	EP2390251A1 Optical pure quinazoline compounds
11/30/2011	EP2390250A2 Gonadotropin releasing hormone receptor antagonists, manufacturing method thereof, and pharmaceutical composition containing same
11/30/2011	EP2390248A1 Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies
11/30/2011	EP2389376A1 Novel bicyclic antibiotics
11/30/2011	EP2389375A2 Hydroxamic acid derivatives
11/30/2011	EP2389374A1 Substituted pyrazinone amides
11/30/2011	EP2217583B1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/30/2011	EP2041069B1 Benzyl amines, a process for their production and their use as anti-inflammatory agents
11/30/2011	EP2010289B1 Benzoazepin-oxy-acetic acid derivatives as ppar-delta agonists used for the increase of hdl-c, lower ldl-c and lower cholesterol
11/30/2011	EP1899324B1 Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
11/30/2011	EP1551810B1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect
11/30/2011	CN1984655B 可用于治疗血栓形成性疾病的p2y1受体脲拮抗剂 P2y1 receptors urea useful in the treatment of thrombotic diseases antagonists

1 ... 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 ... 694